Black Diamond Therapeutics Presents Pre-Clinical Data on Lead Product Candidate BDTX-189 at the 32nd EORTC-NCI-AACR Virtual Symposium

    NEXT STORY
    PCI Biotech: First patient enrolled in Asia in the fimaCHEM pivotal RELEASE study
    PREV STORY
    COVID-19 Diagnostics Market Worth USD 8.04 Billion with Rise at 2.7% CAGR till 2027; Pharmaceutical Giants Such as Abbott and Roche to Pump More Funds for R&D Activities: Fortune Business Insights™
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Rexahn Reports Second Quarter 2018 Financial Results

    ROCKVILLE, Md., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), ...

    author_avatar
    NASDAQ Market News

    UroGen Pharma Reports Second Quarter 2017 Financial Results and Recent Corporate Developments

    Completed Initial Public Offering Raising $66.9 Million in Gross Proceeds Continuing Enrollment of Patients ...

    author_avatar
    NASDAQ Market News

    MacroGenics to Participate in Two Upcoming Investor Conferences

    Rockville, MD, Feb. 27, 2017 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX), a ...

    author_avatar
    NASDAQ Market News